Add-on Valproate in Late Life Schizophrenia
Phase of Trial: Phase IV
Latest Information Update: 23 Sep 2016
At a glance
- Drugs Valproate semisodium (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- 23 Jan 2009 Actual end date changed from Oct 2006 to Nov 2006 as reported by ClinicalTrials.gov.
- 23 Jan 2009 Additional lead trial centres identified as reported by ClinicalTrials.gov, last updated 23-Jan-2009.
- 03 Dec 2005 New trial record.